GLP-1 Monitoring Blood Test Panel in Australia

What this page is, and what FORM does

FORM is a pathology testing service. We measure blood markers and explain what they mean — we do not prescribe, dispense, sell, compound or arrange supply of GLP-1 medicines, and nothing on this page is advice to start, continue or stop any medicine.

GLP-1 receptor agonists are Schedule 4 Prescription Only Medicines in Australia. That means the decision to use one, and every decision that follows, belongs to a registered medical practitioner who has assessed you personally. Australian law also prohibits advertising prescription medicines to the public, which is why this page contains no dosing information, no product comparisons and no commentary on which medicine anyone should be on.

What we can usefully do is the part that is genuinely ours: pathology. A large share of people who begin any form of medically supervised metabolic treatment do so without a full set of baseline bloods on record, and that is a real, avoidable problem. Six months later, when a liver enzyme comes back mildly raised or an HbA1c has moved, nobody can say whether that is new, because there is no 'before'.

So the whole purpose of this panel is unglamorous: create the 'before'. Then repeat it on a sensible schedule so the 'after' means something. Everything below is about what to measure and how to read it.

The core baseline panel: what each marker is for

The standard metabolic baseline is HbA1c, fasting glucose, a full lipid panel, liver function tests and thyroid function, usually alongside a full blood count and renal function.

None of these are exotic tests. They are the markers an Australian GP would typically run when assessing metabolic health, and they are cheap, standardised and reported in the same units by every accredited laboratory in the country. Their value is not novelty, it is comparability over time.

The table below sets out what each marker measures, the ranges Australian laboratories typically report, and why it earns its place in the panel.

Why a baseline is worth more than a later test on its own

A single result tells you where you are; a baseline plus a repeat tells you what direction you are moving in and how fast, which is almost always the more useful information.

Consider an ALT of 48 U/L. In isolation, that is a mildly raised liver enzyme with a long list of possible explanations, and it typically triggers a work-up: repeat testing, sometimes imaging, sometimes hepatitis serology. Now suppose a baseline from six months earlier showed 62 U/L. The same 48 is now a clearly improving number, and the conversation with your GP is completely different.

The same logic applies to HbA1c. A result of 44 mmol/mol (6.2%) sits in the high-risk band, but whether it represents deterioration from 39 or improvement from 52 is not knowable from the number alone. Australian guidance treats HbA1c as a trend marker for exactly this reason — it reflects roughly three months of average glucose, so it is designed to be repeated and compared, not read once.

Baselines are also the only defence against attribution error. Fatty liver, subclinical thyroid disease and dyslipidaemia are all common and all usually silent. If they are present before anything changes and nobody looked, they get attributed to whatever happened next.

• Measure before, not just after — the pre-treatment number is the one that cannot be recreated later.
• Keep conditions consistent: same fasting state, similar time of morning, ideally the same laboratory network, so assay differences do not masquerade as change.
• Keep your PDF reports. Australian laboratories report the reference interval alongside every result, which is what makes an old report readable years later.

How often repeating these bloods is reasonable

For most markers in this panel, a baseline followed by a repeat at around three months and then every six to twelve months while things are stable is a defensible schedule — but your treating doctor sets your actual monitoring interval.

HbA1c sets the natural rhythm. Because red cells live around 120 days, HbA1c cannot meaningfully answer a question asked three weeks apart — the number simply has not had time to move. Around 12 weeks is the shortest interval at which a change is interpretable, which is why three months is the conventional repeat.

Lipids and liver enzymes move faster. Triglycerides in particular respond within weeks to changes in weight, alcohol and carbohydrate intake, and ALT often follows the same direction over a slightly longer horizon. If a baseline showed something abnormal, an earlier repeat than three months may be appropriate — that is a clinical decision for the doctor managing you.

Thyroid function is usually a baseline-and-when-indicated test rather than a routine serial one, unless the baseline was abnormal or symptoms suggest a reason to look again.

When HbA1c misleads

HbA1c is a red-cell measurement, so anything that changes red-cell lifespan or haemoglobin structure changes the result independently of glucose.

Iron deficiency without anaemia tends to raise HbA1c, sometimes by enough to move someone across a diagnostic band, and it corrects when the iron deficiency is treated. This matters in Australia because iron deficiency is common, particularly in menstruating women, and it is not always looked for before an HbA1c is interpreted.

In the opposite direction, anything that shortens red-cell survival — haemolysis, recent significant blood loss, chronic kidney disease, recent blood donation — tends to lower HbA1c relative to true average glucose. Haemoglobin variants, which are not rare in Australia's population, can interfere with some HbA1c assays altogether.

This is the practical argument for measuring fasting glucose and a full blood count in the same draw rather than ordering HbA1c alone. When HbA1c and fasting glucose disagree markedly, the discrepancy itself is the finding, and it is what prompts a doctor to look for a reason.

How to prepare, and how the collection works

Fast 8–12 hours with water allowed, attend an accredited collection centre in the morning, and keep conditions consistent between repeats.

Fasting matters for glucose and triglycerides, and much less for HbA1c, liver enzymes or TSH. Because the panel includes glucose and lipids, the simplest instruction is to fast for the whole panel and collect in the morning.

Alcohol is worth avoiding for 48–72 hours before collection: it raises GGT and triglycerides briefly and can produce an abnormal-looking liver picture that resolves on repeat. Similarly, a very heavy training session in the preceding day or two can raise AST, since AST is also released by muscle.

• No referral from your own GP is required. Privately requested pathology is arranged under a request from a registered medical practitioner working with our accredited lab partner.
• Collection is a walk-in blood draw at Laverty (Healius) pathology centres Australia-wide (NATA / ISO 15189 accredited).
• Results are returned in Australian SI units — mmol/mol and % for HbA1c, mmol/L for glucose and lipids, U/L for liver enzymes — with a written plain-English explanation.
• Your results are yours. Take them to your GP, an endocrinologist or whichever registered practitioner is managing your care; decisions about any medicine are theirs and yours, not ours.
• Australian ordering is currently pre-sale. Join the waitlist and we will email you when ordering opens.

Who this panel is worth doing

Anyone whose metabolic health is actively changing — through medically supervised treatment, significant weight change, or a family history that puts them at risk — benefits from having these markers on record and repeated.

• People whose doctor is assessing them for, or already managing them with, any form of metabolic or weight-related treatment, who want the underlying numbers documented properly.
• People with a first-degree relative with type 2 diabetes, where an HbA1c in the 39–47 mmol/mol band is the actionable early finding.
• People with central weight gain, hypertension or a raised waist circumference, where fatty liver and dyslipidaemia frequently coexist and are silent.
• People experiencing unexplained weight change in either direction, where checking thyroid function before assuming a metabolic cause is standard.
• Anyone who has been told their bloods were 'fine' without being given the actual numbers, and wants a documented baseline they own.

Which panel covers these markers

Every marker in the core baseline set is carried by the standard FORM Australia panels, and each can also be selected individually in the custom builder.

Essential covers HbA1c, fasting glucose, the full lipid panel, liver function tests, thyroid function, full blood count and renal function — which is the complete baseline set described above. Pro and above add fasting insulin, ApoB and hs-CRP, which describe insulin resistance and vascular risk in more detail than glucose and standard lipids alone.

If you only want the metabolic markers and none of the hormone panel, the builder is usually the cheaper route.

• Australian blood test panels (Essential to Ultra) — Essential carries the full baseline metabolic set; Pro and above add fasting insulin, ApoB and hs-CRP.
• Build your own Australian panel — Select HbA1c, glucose, lipids, LFTs and TSH individually and skip everything you do not need.
• HbA1c test — The single marker in most detail — diagnostic thresholds, mmol/mol to % conversion, and what distorts it.
• Thyroid function test — TSH and free T4 — the standard check before unexplained weight change is called metabolic.
• Iron studies — Iron deficiency distorts HbA1c upwards, which is why the two are worth reading together.